Updated
AbbVieABBV · Healthcare
$293.30+0.68%
Market cap$518.4B
IndustryDrug Manufacturers - General
AbbVie (ABBV) Superinvestor holders
43 of the superinvestors we track hold AbbVie (ABBV) in their latest 13F filings, $8.8B in total.
Summary
The largest holder is Ken Fisher (Fisher Investments), with $2.6B, 0.8% of the portfolio.
In their latest quarter: 5 opened a new position, 17 added, 17 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ken Fisher Fisher Investments |
Added | 10,063,539 | $2.6B | 0.8% | Q3 2026 |
| Mark Donovan Boston Partners |
Added | 4,784,316 | $1.2B | 1.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 2,990,512 | $753M | 0.6% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 2,876,785 | $724M | 1.7% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 2,027,797 | $530M | 0.6% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 2,102,316 | $529M | 0.3% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 2,015,238 | $507M | 0.2% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 1,704,016 | $429M | 0.8% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 861,436 | $217M | 0.4% | Q2 2026 |
| Arrowstreet Capital | Added | 856,797 | $216M | 0.1% | Q2 2026 |
| Jennison Associates | Trimmed | 679,544 | $171M | 0.1% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 594,732 | $150M | 0.4% | Q2 2026 |
| Thornburg Thornburg Investment Management |
Added | 541,146 | $136M | 1.3% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Added | 380,290 | $96M | 0.4% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 366,836 | $92M | 0.1% | Q2 2026 |
| Harding Loevner | Trimmed | 279,294 | $70M | 0.7% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 198,249 | $50M | 0.0% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
New position | 148,913 | $37M | 0.7% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 115,264 | $29M | 0.4% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 108,867 | $27M | 0.1% | Q2 2026 |
| Robert Torray Torray Investment Partners |
Added | 83,376 | $22M | 2.9% | Q3 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 82,422 | $21M | 0.0% | Q2 2026 |
| Bernard Horn Polaris Capital Management |
Trimmed | 66,394 | $17M | 1.8% | Q3 2026 |
| Alger Fred Alger Management |
Trimmed | 67,742 | $17M | 0.1% | Q2 2026 |
| Howard Gleicher Aristotle Capital Management |
Trimmed | 63,964 | $16M | 0.0% | Q2 2026 |
| Alan Breed Edgewood Management |
Held | 45,542 | $11M | 0.1% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Trimmed | 44,702 | $11M | 0.1% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 43,544 | $11M | 0.0% | Q2 2026 |
| David Katz Matrix Asset Advisors |
Trimmed | 33,896 | $9M | 0.7% | Q3 2026 |
| Peter Muller PDT Partners |
Added | 35,200 | $9M | 0.5% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Held | 27,300 | $7M | 0.3% | Q3 2026 |
| Eric Marshall Hodges Capital Management |
Trimmed | 19,642 | $5M | 0.3% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Trimmed | 18,887 | $5M | 0.1% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | 13,603 | $3M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Added | 12,752 | $3M | 0.1% | Q2 2026 |
| Tom Russo Gardner Russo & Quinn |
Held | 12,410 | $3M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 11,775 | $3M | 0.0% | Q2 2026 |
| Jensen Investment Management | Trimmed | 11,064 | $3M | 0.1% | Q2 2026 |
| Dodge & Cox | Held | 10,393 | $3M | 0.0% | Q2 2026 |
| Josef Lakonishok LSV Asset Management |
New position | 4,000 | $1M | 0.0% | Q3 2026 |
| Brandon Haley Holocene Advisors |
New position | 3,855 | $970,072 | 0.0% | Q2 2026 |
| Bill Nygren Harris Associates LP |
Trimmed | 2,420 | $608,969 | 0.0% | Q2 2026 |
| Jeremy Grantham GMO |
New position | 885 | $222,701 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 42 |
| Q1 2026 | 40 |
| Q4 2025 | 38 |
| Q3 2025 | 43 |
| Q2 2025 | 46 |
| Q1 2025 | 44 |
| Q4 2024 | 41 |
| Q3 2024 | 39 |
Questions about AbbVie
Which superinvestors own AbbVie?
43 of the superinvestors we track hold AbbVie (ABBV) in their latest 13F filings, $8.8B in total. Ken Fisher, Mark Donovan, Paul Marshall, Fayez Sarofim, Acadian, David Shaw.
Who is the largest superinvestor holder of ABBV?
The largest holder is Ken Fisher (Fisher Investments), with $2.6B, 0.8% of the portfolio.
From AbbVie's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.